These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 992883)

  • 1. A quick and reliable process for preparing 99mTc--1: hydroxy-ethylidene-1, 1-diphosphonic acid disodium salt (HEDSPA) using electrolysis.
    Belkas EP; Varvarigou AD
    Int J Appl Radiat Isot; 1976 Oct; 27(10):590-1. PubMed ID: 992883
    [No Abstract]   [Full Text] [Related]  

  • 2. Method for the synthesis of 1-hydroxy-ethylidene-1, 1-disodium phosphonate (HEDSPA): a skeletal seeking radiopharmaceutical after labeling with 99mTc.
    Castronovo FP
    J Nucl Med; 1974 Feb; 15(2):127-30. PubMed ID: 4810582
    [No Abstract]   [Full Text] [Related]  

  • 3. Method for the synthesis of the skeletal seeking agent 1-hydroxy-ethylidene-1,1-disodium phosphonate (HEDSPA) and its subsequent labelling with 99mTc.
    Castronovo FP
    Int J Nucl Med Biol; 1973 Nov; 1(2):109-13. PubMed ID: 4803260
    [No Abstract]   [Full Text] [Related]  

  • 4. 99mTc-labelled compounds prepared with sodium dithionite as reducing agent.
    Vilcek S; Kalincák M; Machán V
    Nuklearmedizin; 1981 Dec; 20(6):283-9. PubMed ID: 6460222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrolytical labeling of 99mTc radiopharmaceuticals.
    Gil MC; Palma T; Radicella R
    Int J Appl Radiat Isot; 1976 Feb; 27(2):69-72. PubMed ID: 175805
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis, radiotechnetium labelling, and comparison of biologic behavior of longer-chain analogs of methylene diphosphonate.
    Wang TS; Hosain P; Spencer RP; Ahlquist K; Hosain F
    J Nucl Med; 1978 Oct; 19(10):1151-3. PubMed ID: 722328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of compounds labeled with technetium (99m Tc) produced by electrolysis].
    Watanabe K; Kawahira K; Kamoi I; Morita K
    Kaku Igaku; 1974 Dec; 11(6):693-700. PubMed ID: 4478018
    [No Abstract]   [Full Text] [Related]  

  • 8. [99MTechnetium-fibrinogen labeling using electrolytic zircuronium release].
    Hebestreit HP; Pryss C
    Nucl Med (Stuttg); 1975 Jun; 14(2):172-84. PubMed ID: 1178516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technetium-99m APD compared with technetium-99m MDP as a bone scanning agent.
    Degrossi OJ; Oliveri P; García del Río H; Labriola R; Artagaveytía D; Degrossi EB
    J Nucl Med; 1985 Oct; 26(10):1135-9. PubMed ID: 4045556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of four techniques for labeling albumin microspheres with technetium-99m.
    Mayron LW; Kaplan E
    Int J Nucl Med Biol; 1975 Mar; 2(2):74-80. PubMed ID: 1176265
    [No Abstract]   [Full Text] [Related]  

  • 11. Bone-seeking properties of Tc-99m carbonyl diphosphonic acid, dihydroxy-methylene diphosphonic acid and monohydroxy-methylene phosphoinic acid: concise communication.
    Wang TS; Fawwaz RA; Johnson LJ; Mojdehi GE; Johnson PM
    J Nucl Med; 1980 Aug; 21(8):767-70. PubMed ID: 7400832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A portable test system for determination of bacterial endotoxins in 18F-FDG, 99mTc, and lyophilized reagents for labeling with 99mTc.
    Fukumori NT; de Campos DG; Massicano AV; de Pereira NP; da Silva CP; Matsuda MM
    J Nucl Med Technol; 2011 Jun; 39(2):121-4. PubMed ID: 21565953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Radiochemical purity and stability of 99mTc-MDP for bone scintigraphy (author's transl)].
    Yoshino T; Watanabe N; Kawahara Y; Okada K; Nishimura I
    Radioisotopes; 1980 Aug; 29(8):398-400. PubMed ID: 6451900
    [No Abstract]   [Full Text] [Related]  

  • 14. Carrier electrochemistry of pertechnetate: application to radiopharmaceutical labelling by controlled potential electrolysis at chemically inert electrodes.
    Russell CD
    Int J Appl Radiat Isot; 1977 Mar; 28(3):241-9. PubMed ID: 405335
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of stannous methylene diphosphonate for labelling red blood cells with 99m Tc.
    Khan RA
    Experientia; 1978 Feb; 34(2):261. PubMed ID: 624370
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of technetium-99m labeled 1-hydroxy-ethylidene-1,1-disodium phosphonate for skeletal imaging.
    Callahan RJ; Castronovo FP
    Am J Hosp Pharm; 1973 Jul; 30(7):614-7. PubMed ID: 4715107
    [No Abstract]   [Full Text] [Related]  

  • 17. The chemistry of technetium labeling of radiopharmaceuticals by electrolysis.
    Steigman J; Eckelman WC; Meinken G; Isaacs HS; Richards P
    J Nucl Med; 1974 Feb; 15(2):75-80. PubMed ID: 4810593
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of redox polymers for insulin labeling with technetium (99mTc)].
    Komárek P; Kleisner I; Konopková M; Komárková I
    Ceska Slov Farm; 1999 Sep; 48(5):218-20. PubMed ID: 10566241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technetium-99m-human fibrinogen.
    Wong DW; Mishkin FS
    J Nucl Med; 1975 May; 16(5):343-7. PubMed ID: 1194984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiopharmaceuticals labelled with technetium.
    Eckelman WC; Levenson SM
    Int J Appl Radiat Isot; 1977; 28(1-2):67-82. PubMed ID: 192683
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.